Kovack Advisors, Inc. Abb Vie Inc. Call Options Transaction History

Kovack Advisors, Inc.

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2019 May 03, 2019	BUY	$77.14 - $90.79 $77 - $90	1 Added 100.0%	2 $1,000
Q4 2018 Feb 06, 2019	SELL	$77.85 - $96.01 $311 - $384	-4 Reduced 80.0%	1 $1,000
Q2 2017 Aug 30, 2018	SELL	N/A	-18 Reduced 78.26%	5 $7,000
Q4 2016 Sep 10, 2018	BUY	N/A	7 Added 43.75%	23 $8,000
Q3 2016 Sep 25, 2018	SELL	N/A	-3 Reduced 15.79%	16 $4,000
Q2 2016 Oct 01, 2018	BUY	N/A	19	19 $7,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Kovack Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Kovack Advisors, Inc. with notifications on news.